What is Doctify?
Doctify, founded in 2015 and headquartered in Greater London, UK, operates as a health-tech platform. Developed by medical professionals, it serves healthcare providers, doctors, and patients, aiming to streamline healthcare access and delivery. The company's focus on bridging the gap between medical expertise and patient needs positions it as a key player in the digital health transformation.
How much funding has Doctify raised?
Doctify has raised a total of $7.5M across 1 funding round:
Other Financing Round
$7.5M
Other Financing Round (2021): $7.5M with participation from Amadeus Capital Partners, Keen Venture Partners LLP, and GAM Investments Pty Ltd
Key Investors in Doctify
Amadeus Capital Partners
Amadeus Capital Partners is a London-based global technology venture capital firm that invests in high-growth companies across sectors such as artificial intelligence, digital health, cybersecurity, enterprise software, fintech, and deep tech.
Keen Venture Partners LLP
Keen Venture Partners LLP is an investment firm that likely focuses on supporting growth-stage companies with strategic capital.
GAM Investments Pty Ltd
GAM Investments Pty Ltd is an asset management firm that may provide significant financial backing to companies with strong market potential.
What's next for Doctify?
The recent major strategic investment indicates Doctify is poised for significant scaling and further development of its platform. This capital infusion will likely fuel expansion into new markets, enhance technological capabilities, and strengthen partnerships within the healthcare ecosystem. The company's enterprise-level funding context suggests a mature stage of growth, focusing on solidifying its market leadership and driving innovation in health-tech solutions.
See full Doctify company page
